CD4 and cancer: We showed that the Rs had significantly fewer CD3+, CD8+ and CD56+ lymphocytes than the PTs, but that the amounts of CD4+ cells remained similar in the PTs and the Rs, suggesting that CD4+ cells could play an important role in cancer immunoescape.